Steven Wheen
Stock Analyst at Jarden
(4.08)
# 1,655
Out of 5,028 analysts
245
Total ratings
50%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by Steven Wheen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: HLS Healius Limited | Reiterated: Hold | $0.50 → $0.54 | $0.41 | +33.33% | 34 | Sep 28, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $21.00 | $15.59 | +34.70% | 33 | Sep 22, 2026 | |
| ASX: REG Regis Healthcare Limited | Reiterated: Hold | $7.50 → $6.20 | $4.40 | +41.07% | 18 | Sep 3, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Buy | $47.60 → $53.00 | $54.31 | -2.41% | 29 | Aug 28, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.25 → $2.95 | $2.15 | +37.21% | 24 | Aug 26, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Hold | $22.30 → $22.90 | $18.56 | +23.38% | 30 | Aug 21, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | $169.00 → $165.00 | $129.82 | +27.10% | 17 | Aug 19, 2026 | |
| ASX: CSL CSL Limited | Upgraded: Buy | $191.00 → $207.00 | $177.09 | +16.89% | 34 | Aug 19, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Buy | $40.20 → $39.90 | $31.65 | +26.07% | 23 | Aug 10, 2026 | |
| ASX: QBE QBE Insurance Group Limited | Reiterated: Hold | $22.00 | $23.57 | -6.66% | 1 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.71 → $0.75 | $0.50 | n/a | 2 | Nov 27, 2024 |
Healius Limited
Sep 28, 2026
Reiterated: Hold
Price Target: $0.50 → $0.54
Current: $0.41
Upside: +33.33%
Telix Pharmaceuticals Limited
Sep 22, 2026
Reiterated: Buy
Price Target: $21.00
Current: $15.59
Upside: +34.70%
Regis Healthcare Limited
Sep 3, 2026
Reiterated: Hold
Price Target: $7.50 → $6.20
Current: $4.40
Upside: +41.07%
Ramsay Health Care Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $47.60 → $53.00
Current: $54.31
Upside: -2.41%
Integral Diagnostics Limited
Aug 26, 2026
Reiterated: Buy
Price Target: $3.25 → $2.95
Current: $2.15
Upside: +37.21%
Sonic Healthcare Limited
Aug 21, 2026
Reiterated: Hold
Price Target: $22.30 → $22.90
Current: $18.56
Upside: +23.38%
Cochlear Limited
Aug 19, 2026
Reiterated: Hold
Price Target: $169.00 → $165.00
Current: $129.82
Upside: +27.10%
CSL Limited
Aug 19, 2026
Upgraded: Buy
Price Target: $191.00 → $207.00
Current: $177.09
Upside: +16.89%
ResMed Inc.
Aug 10, 2026
Reiterated: Buy
Price Target: $40.20 → $39.90
Current: $31.65
Upside: +26.07%
QBE Insurance Group Limited
Feb 20, 2026
Reiterated: Hold
Price Target: $22.00
Current: $23.57
Upside: -6.66%
Nov 27, 2024
Reiterated: Hold
Price Target: $0.71 → $0.75
Current: $0.50
Upside: n/a